Portal:Drug Metabolism/AllPathways

(Difference between revisions)

Current revision

@@ Line 1: / Line 1: @@
-= Degradation =
+== Mode of Action ==
+<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
+* [[Pathway:WP339|dorsomorphin]]
+* [[Pathway:WP1601|fluoropyrimidine]]
+* nicotine ([[Pathway:WP1603|chromaffin cells]] and [[Pathway:WP1602|dopaminergic neurons]])
+* [[Pathway:WP259|nifedipine]]
+</div>
+== Biotransformations ==
+<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
+* [[Pathway:WP2712|abacavir]]
 * [[Pathway:WP2640|aripiprazole]]
+* [[Pathway:WP2826|cocaine]]
 * [[Pathway:WP1604|codeine]]
 * [[Pathway:WP2536|colchicine]]
 * [[Pathway:WP2561|dantrolene]]
 * [[Pathway:WP2491|diclofenac]]
+* [[Pathway:WP2816|felbamate]]
 * [[Pathway:WP2645|heroin]]
+* [[Pathway:WP2646|lidocaine]]
 * [[Pathway:WP2540|methapyrilene]]
 * [[Pathway:WP1604|morphine]]
 * [[Pathway:WP2537|moxicylyte]]
+* [[Pathway:WP1600|nicotine]]
 * sulindac ([[Pathway:WP2541|rat]] and [[Pathway:WP2542|human]])
 * [[Pathway:WP691|tamoxifen]]
+</div>
+== Receptor binding ==
+<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
+* [[Pathway:WP455|bradykinin]]
+* [[Pathway:WP455|dopamine]]
+* [[Pathway:WP455|histamine]]
+* [[Pathway:WP455|melatonin]]
+* [[Pathway:WP455|prostaglandin]]
+* [[Pathway:WP455|serotonin]]
+</div>